Investment, Financing and M&A
ZSK specializes in private equity investment, venture capital and financing. Attorneys at ZSK have extensive experience in negotiating deals, managing projects, and executing transactions. They leverage their professional expertise to assist clients with transaction planning and structuring, drafting and negotiating transaction documents, conducting legal and IP due diligence, and successfully closing projects aligned with commercial interests.
Venture capital and private equity investment, FDI, merger and acquisition, securities and capital markets, establishment of RMB fund, employee equity incentives, etc.
Real estate, construction, dispute resolution, etc.
Corporate finance, financial capital market (such as listing and refinancing in domestic and foreign capital market), merger & acquisition, private equity investment, project financing (such as mining project financing), real estate development and operation, and other commercial legal services.
Foreign investment, financial capital market (such as domestic and foreign capital market listing, refinancing, etc.), wealth management, family trust, global residence & nationality planning, mergers and acquisitions, private equity investment, project financing (such as mineral resources, etc.), banking and real estate and other commercial legal services.
Venture capital and private equity, merger and acquisition, life sciences and healthcare, wealth management, etc.
Marriage and family, inheritance, labour and employment, litigation and arbitration, corporate compliance, etc.
Venture capital and private equity, securities and capital markets, establishment of RMB fund, employee equity incentives, corporate compliance, etc.
Lihong DUAN is proficient at handling difficult and complex intellectual property and major foreign-related commercial disputes and anti-monopoly cases, including those in pharmaceutical and communications industries, as well as IP-related litigation and other related legal services.
REPRESENTATIVE EXPERIENCE
- Advised Telstra (ASX: TLS) on equity restructuring and equity incentive scheme;
- Advised Botree Cycling on restructuring and several rounds of private equity financing;
- Advised Credo Technology (NASDAQ: CRDO) on Series D financing;
- Advised Sunyur Technology on Series A+, Series B, Series B+ financing;
- Advised RealAI on private equity financing, with investors including China Internet Investment Fund and Ant Group;
- Advised CGP on several rounds of financing, with investors including Morgan Stanley RMB fund;
- Advised Eyedeal on building of red-chip structure and acceptance of investment from USD funds such as PAG, as well as related post-investment matters;
- Advised Ctrl+ Technology on several rounds of financing and restructuring the group’s equity structure;
- Advised Vivame Technology (870672) on several rounds of financing and dismantling red-chip structure and return to China for NEEQ listing;
- Advised Shanzhen on building red-chip structure and acceptance of several rounds of investment from Bluerun and other investors;
- Advised FarmLink on building red-chip structure and acceptance of several rounds of investment from Sequoia, K2VC and others;
- Advised Morgan Stanley RMB fund on its investments in Hongyun Rongtong and other TMT companies;
- Advised Binance on equity restructuring and equity incentive scheme;
- Advised China Broadband Capital and Youshan Capital on investment in Borui Intelligence;
- Advised SIG on acquisition of several domestic high-tech companies;
- Advised Ventech China on investment in SinoCampus, Vivame, shenzhoufu.com, qiandai.com, etc;
- Advised Baidu Network on acquisition of T2Cloud;
- Advised Tianqi (Beijing) on acquisition of Tsingpu Tourism;
- Advised Shanghai Wanye Enterprises on overseas investment in and acquisition of Compart;
- Advised Casstar on investment in LightAI;
- Advised Casstar on investment in LightIC;
- Advised Cash Capital on investment in businesses such as TiJi and Sinotau;
- Advised Matrix Partners on investment in TMT companies such as Jimu and Zhaogang;
- Advised K2VC, Crystal Stream and China Growth Capital on investment in a series of early stage projects;
- Advised Investment Fund for Developing Countries (IFU, a Danish fund) on several investment & financing projects in China, including direct investment, M&A and loan projects;
- Advised Georg Fischer AG, a Swiss company, on its acquisition of equities of two domestic production companies;
- Advised DLG, a Danish group, on its subscription for shares newly issued by a domestic company limited by shares in Henan;
- Advised on the merger of two Finnish WFOEs in China;
- Advised Orient Asset and Cinda Asset on their debt restructuring (with a subject amount of 1 3 billion and 1 5 billion respectively);
- Advised Warburg Pincus Asia LLC on its acquisition of a series of department stores in China;
- Advised Softbank Fund on its acquisition of a media company in China;
- Advised TVG Fund on acquisition of a high-tech company in China;
- Advised DragonTech Fund on acquisition of a high-tech company in China;
- Advised a Chinese chemical company on its acquisition of peer companies in Australia;
- Advised a Fortune 500 company in US on its sale of part of its business in China to another American company;
- Advised Warburg Pincus on its investment in Zhejiang Intime Department Store Co., Ltd. (listed on the Hong Kong Stock Exchange);
- Advised Warburg Pincus on its investment in Beijing Wangfujing Department Store (Group) Co., Ltd. (a domestic listed company);
- Advised Warburg Pincus on its investment in Gome Electrical Appliances Holdings Ltd (a company listed on the Hong Kong Stock Exchange);
- Advised Citic Capital on its investment in Fushun Excavator Manufacturing Co., Ltd.;
- Advised KPCB on its investment in Beijing Venustech Inc (listed on the domestic SME board);
- Advised Ping’an Innovation Capital on its investment in XJ Group Corporation;
- Advised CDH Investments on its investment in Himin Solar Group Co., Ltd.;
- Advised Yunnan Copper Co., Ltd., a domestic listed company, on its investment in Yunnan Hualian Zinc & Indium Stock Co., Ltd.;
- Advised a Hong Kong funded investment company on acquisition of equity in two domestic medical beauty institutions.
